Addition of botulinum toxin type A to casting may improve wrist extension in people with chronic stroke and spasticity: A pilot double-blind randomized trial

dc.contributor.authorScott, Hayley
dc.contributor.authorLannin, Natasha A
dc.contributor.authorEnglish, Coralie
dc.contributor.authorAda, Louise
dc.contributor.authorLevy, Tamina
dc.contributor.authorHart, Rhiannon
dc.contributor.authorCrotty, Maria
dc.date.accessioned2018-10-12T06:01:06Z
dc.date.available2018-10-12T06:01:06Z
dc.date.issued2017-03-15
dc.descriptionThis article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.en_US
dc.description.abstractAims: Does the addition of botulinum toxin type A increase the effect of casting for improving wrist extension after stroke in people with upper limb spasticity? Methods: Randomized trial with concealed allocation, assessor blinding and intention-to-treat analysis which was part of a larger trial included 18 adults with upper limb spasticity two years after stroke (89%) or stroke-like conditions (11%). The experimental group (n=7) received botulinum toxin type A injections to upper limb muscles for spasticity management followed by two weeks of wrist casting into maximum extension. The control group (n=11) received two weeks of casting only. Range of motion (goniometry) measured at baseline and after two weeks of casting. Results: Passive wrist extension for the experimental group improved over two weeks from 22 degrees (SD 16) to 54 degrees (SD 16), while the control group improved from 21 degrees (SD 29) to 43 degrees (SD 26). The experimental group increased passive wrist extension 13 degrees (95% CI 4 to 31) more than the control group which was not statistically significant. Conclusion: Joint range of motion improved over a two-week period for both groups. Botulinum toxin type A injection followed-by casting produced a mean, clinically greater range of motion than casting alone, therefore, a fully-powered trial is warranted.en_US
dc.description.sponsorshipNoneen_US
dc.identifier.citationScott, H., Lannin, N.A., English, C., Ada, L., Levy, T., Hart, R., Crotty, M., (2017). Addition of botulinum toxin type A to casting may improve wrist extension in people with chronic stroke and spasticity: A pilot double-blind randomized trial. Edorium Journal of Disability and Rehabilitation, 3: 30-35.en_US
dc.identifier.doihttps://doi.org/10.5348/D05-2017-28-OA-4en_US
dc.identifier.urihttp://hdl.handle.net/2328/38409
dc.language.isoenen_US
dc.oaire.license.condition.licenseCC-BY
dc.publisherEndorium Journalsen_US
dc.rights© 2017 Hayley Scott et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.en_US
dc.rights.holder© 2017 Hayley Scott et al.en_US
dc.subjectContractureen_US
dc.subjectmuscle spasticityen_US
dc.subjectRehabilitationen_US
dc.subjectSerial castsen_US
dc.subjectstretchen_US
dc.titleAddition of botulinum toxin type A to casting may improve wrist extension in people with chronic stroke and spasticity: A pilot double-blind randomized trialen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Scott_Addition_P2018.pdf
Size:
499.96 KB
Format:
Adobe Portable Document Format
Description:
Published version
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.84 KB
Format:
Item-specific license agreed upon to submission
Description: